PBAC's latest decision on Trivalent influenza vaccine: Recommended (2014). Considered for Annual vaccination for Aboriginal and Torres Strait Islander children aged 6 months to 5 years to prevent influenza infection and reduce disease severity.
PBAC outcome
Recommended
Unrestricted
ICER (AUD/QALY)
Not modelled
no economic evaluation
Submissions
1
first 2014
Submissions
1
2014 → 2014
Eligible population
Aboriginal and Torres Strait Islander children aged 6 months to 5 years.
Therapy area
Vaccines
Line of therapy
Not applicable
Evidence base
Other
Primary endpoint
Other
Comparator
medically at risk cohort (children with underlying medical conditions already funded under NIP)
Economic model
Cost-minimisation
Budget impact
$1M
Eligible patients/year
68,000
ICER note
No formal economic analysis was provided; cost-effectiveness was inferred by comparison with funded medically at-risk cohort rather than by explicit ICER calculation.